Sildenafil 4.0—Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era

Sildenafil is a potent selective, reversible inhibitor of phosphodiesterase type 5 (PDE5) approved for the treatment of erectile dysfunction and pulmonary arterial hypertension. Whilst twenty years have passed since its original approval by the US Food and Drug Administration (USFDA), sildenafil ent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Ouranidis, Andreas, Tsiaxerli, Anastasia, Vardaka, Elisavet, Markopoulou, Catherine K., Zacharis, Constantinos K., Nicolaou, Ioannis, Hatzichristou, Dimitris, Haidich, Anna-Bettina, Kostomitsopoulos, Nikolaos, Kachrimanis, Kyriakos
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071249/
https://ncbi.nlm.nih.gov/pubmed/33920975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados